Tuesday, February 27, 2024 8:00:14 PM
See that 8K announcing the revolving credit line of $1 million. Under pledge and security agreement, exhibit "A" labeled "collateral" they appear to be committing all assets including that of American Treatment Holdings, Inc (ATHI) which is the holding company for the shares of the Evernia treatment center. Now will they be paying off the lenders who have debt secured by options against the direct shares of ATHI?
One of Shawn Leon's favorite tactics is to find new borrowed funds to pay off existing debt and announce in a press release that they paid off the debt. This is what he did with the crazy property purchase, sale, leaseback deal last summer where essentially refinancing the defaulted debt over a 20 year period resulting is a million in expenses. Now that defaulted debt that they weren't paying on must be serviced every month. Traders chased that up to $0.0007 before once again realizing that they had been duped. He did this with the large Leonite note of June 2022 which eventually went into default and again the hapless chased the news. It really is fun to watch Shawn Leon dig this hole even deeper and still not be able to raise any funds off that regulation "A" offering. 🤣
FORM 8K
https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/0000792935/000190359624000061/grst_8k.htm
TEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
Testing 123, LLC (“Testing”)
On February 1, 2024 Ethema Health Corporation, American Treatment Holdings Inc, and Evernia Health Center LLC (the “Company” or “Companies”) entered into a revolving line of credit agreement (“ Agreement”) with Testing. The term of the Agreement is two years and the maximum amount that may be drawn down is $1,000,000.00.
Pledge and Security Agreement
https://www.sec.gov/Archives/edgar/data/792935/000190359624000061/ex10_03.htm
Everything that I post is just my informed opinion and is simply an invitation to debate. Trade on your own due diligence please..
Recent GRST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2024 09:45:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2023 09:54:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/22/2023 09:04:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:55:26 PM
- Form 1-A POS - • Edgar (US Regulatory) • 10/20/2023 07:29:40 PM
- Form 1-A POS - • Edgar (US Regulatory) • 08/29/2023 07:21:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:37:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 12:43:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 04:51:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2023 06:56:41 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM